Skip to main content

Table 2 Significantly differentially expressed genes in peripheral blood mononuclear cells of patients with different clinical subtypes of late AMD

From: The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration

Gene name

Description

FC %

P-value

Patients with GA

 SNORA14A

small nucleolar RNA, H/ACA box 14A

101

0.031

 USP32P1

ubiquitin specific peptidase 32 pseudogene 1

67

< 0.001

 SLC14A1

solute carrier family 14 (urea transporter), member 1 (Kidd blood group)

62

0.002

 MIR4516

microRNA 4516

59

0.020

 DDA1

DET1 and DDB1 associated 1

46

0.033

 MIR3665

microRNA 3665

44

< 0.001

 SNORA49

small nucleolar RNA, H/ACA box 49

43

0.025

 MIR4509–1

microRNA 4509–1

39

0.024

 TMEM120A

transmembrane protein 120A

38

0.004

 LY6E

lymphocyte antigen 6 complex, locus E

35

0.021

 IFITM1

interferon induced transmembrane protein 1

35

0.033

 CSNK1G2

casein kinase 1, gamma 2

34

0.015

 NINJ1

ninjurin 1

33

0.003

 HSH2D

hematopoietic SH2 domain containing

33

0.009

 GIMAP1-GIMAP5

GIMAP1-GIMAP5 readthrough

32

0.030

 LINC01000

long intergenic non-protein coding RNA 1000

32

0.026

 SNORD88A

small nucleolar RNA, C/D box 88A

32

0.014

 CAMKK2

calcium/calmodulin-dependent protein kinase kinase 2, beta

32

0.049

 KRT73

keratin 73, type II

32

0.034

 SDF4

stromal cell derived factor 4

31

0.012

 CD247

CD247 molecule

31

0.042

 TMSB4XP4

thymosin beta 4, X-linked pseudogene 4

31

0.026

 CD200R1

CD200 receptor 1

31

0.032

 CISH

cytokine inducible SH2-containing protein

31

0.011

 MX2

MX dynamin-like GTPase 2

30

0.035

 MICALCL

MICAL C-terminal like

30

0.026

 CD5

CD5 molecule

30

0.037

 C15orf54

chromosome 15 open reading frame 54

− 108

0.008

 RNU4ATAC

RNA, U4atac small nuclear (U12-dependent splicing)

− 91

0.031

 LOC105370195

uncharacterized LOC105370195

− 89

0.012

 MYCT1

myc target 1

−67

0.011

 MS4A1

membrane-spanning 4-domains, subfamily A, member 1

−64

0.045

 LOC105377384

uncharacterized LOC105377384

−56

0.034

 OR2L1P

olfactory receptor, family 2, subfamily L, member 1 pseudogene

−55

0.006

 LOC105379818

uncharacterized LOC105379818

−51

0.021

 CD1C

CD1c molecule

−49

0.001

 LOC105369884

uncharacterized LOC105369884

−49

0.002

 LOC102724714

uncharacterized LOC102724714

−47

0.030

 RSU1

Ras suppressor protein 1

−47

0.010

 TNFSF4

tumor necrosis factor (ligand) superfamily, member 4

−46

0.028

 SNORD42A

small nucleolar RNA, C/D box 42A

−45

0.026

 WDR11-AS1

WDR11 antisense RNA 1

− 43

0.025

 LINC00989

long intergenic non-protein coding RNA 989

−43

0.043

 CRYZ

crystallin zeta

−43

0.016

 DNM3

dynamin 3

−43

0.012

 LINC00266–1

long intergenic non-protein coding RNA 266–1

−42

0.021

 SLFN14

schlafen family member 14

−40

0.029

 HIST1H2BC

histone cluster 1, H2bc

−38

0.016

 GFI1B

growth factor independent 1B transcription repressor

−37

0.016

 PF4

platelet factor 4

−37

0.015

 PPIAL4A

peptidylprolyl isomerase A (cyclophilin A)-like 4A

−36

0.041

 SENCR

smooth muscle and endothelial cell enriched migration/differentiation-associated lncRNA

−36

0.002

 LOC101928979

uncharacterized LOC101928979

−35

0.023

 MIR1321

microRNA 1321

−34

0.016

 CTTN

cortactin

−33

0.033

 GRB14

growth factor receptor bound protein 14

−32

0.008

 PCYT1B

phosphate cytidylyltransferase 1, choline, beta

−32

0.028

 P2RY1

purinergic receptor P2Y, G-protein coupled, 1

−32

0.011

 KCNQ5-IT1

KCNQ5 intronic transcript 1

−32

0.037

 FAM111B

family with sequence similarity 111, member B

−32

0.014

 GUSBP1

glucuronidase, beta pseudogene 1

−31

0.033

 LIMS1

LIM and senescent cell antigen-like domains 1

−31

0.016

Patients with nAMD

 OSBP2

oxysterol binding protein 2

151

0.002

 IGHV1OR21–1

immunoglobulin heavy variable 1/OR21–1 (non-functional)

106

0.013

 ANK1

ankyrin 1, erythrocytic

83

0.002

 PITHD1

PITH (C-Terminal Proteasome-Interacting Domain Of Thioredoxin-Like) Domain Containing 1

82

0.009

 MIR4644

microRNA 4644

64

0.027

 MARCH8

membrane associated ring finger 8

61

0.001

 PAGE2B

P antigen family, member 2B

60

0.009

 TMOD1

tropomodulin 1

60

0.013

 HBD

hemoglobin, delta

56

0.003

 LOC401127

WD repeat domain 5 pseudogene

51

0.018

 RHD

Rh blood group, D antigen

48

0.036

 TRBV7–4

T cell receptor beta variable 7–4 (gene/pseudogene)

48

0.001

 USP32P1

ubiquitin specific peptidase 32 pseudogene 1

47

0.038

 FAM210B

family with sequence similarity 210, member B

47

0.027

 BPGM

2,3-bisphosphoglycerate mutase

47

0.040

 FECH

ferrochelatase

45

0.009

 LINC01291

long intergenic non-protein coding RNA 1291

44

< 0.001

 HBM

hemoglobin, mu

43

0.015

 MMP8

matrix metallopeptidase 8

43

0.004

 DCAF12

DDB1 and CUL4 associated factor 12

41

0.044

 FAM46C

family with sequence similarity 46, member C

40

0.043

 LTF

lactotransferrin

39

0.001

 PGLYRP1

peptidoglycan recognition protein 1

37

0.007

 CAMP

cathelicidin antimicrobial peptide

35

0.010

 SLC25A39

solute carrier family 25, member 39

34

0.010

 SLC14A1

solute carrier family 14 (urea transporter), member 1 (Kidd blood group)

34

0.013

 SLC25A37

solute carrier family 25 (mitochondrial iron transporter), member 37

32

0.009

 SLC4A1

solute carrier family 4 (anion exchanger), member 1 (Diego blood group)

31

0.001

 IFIT1B

interferon-induced protein with tetratricopeptide repeats 1B

31

0.002

 AHSP

alpha hemoglobin stabilizing protein

31

0.015

 ALAS2

5-aminolevulinate synthase 2

30

0.001

 RNU4ATAC

RNA, U4atac small nuclear (U12-dependent splicing)

− 125

0.002

 SNORD3C

small nucleolar RNA, C/D box 3C

−66

0.028

 ADAM28

ADAM metallopeptidase domain 28

− 48

0.017

 RNU5E-1

RNA, U5E small nuclear 1

−42

0.044

 SNORD12C

small nucleolar RNA, C/D box 12C

−41

0.026

 FRG1JP

FSHD region gene 1 family member J, pseudogene

−37

0.005

 MIR1537

microRNA 1537

−36

0.025

 CD1C

CD1c molecule

−34

0.004

 SNAR-G2

small ILF3/NF90-associated RNA G2

− 34

0.018

 LOC105374775

uncharacterized LOC105374775

−31

0.033

Patients with PCV

 TRIM48

tripartite motif containing 48

146

0.040

 LOC105373103

uncharacterized LOC105373103

54

0.026

 TRAJ13

T cell receptor alpha joining 13

45

0.046

 SLC14A1

solute carrier family 14 (urea transporter), member 1 (Kidd blood group)

44

0.040

 IGKV1–12

immunoglobulin kappa variable 1–12

42

0.024

 LTF

lactotransferrin

41

0.050

 TRAV8–4

T cell receptor alpha variable 8–4

40

0.041

 IGHG4

immunoglobulin heavy constant gamma 4 (G4 m marker)

37

0.021

 IGKV2D-24

immunoglobulin kappa variable 2D-24 (non-functional)

34

0.024

 SNORA71D

small nucleolar RNA, H/ACA box 71D

34

0.013

 FAR2P3

fatty acyl-CoA reductase 2 pseudogene 3

30

0.011

 LOC101928215

uncharacterized LOC101928215

−81

0.001

 SNORD117

small nucleolar RNA, C/D box 117

− 76

0.017

 SNORD63

small nucleolar RNA, C/D box 63

−73

0.017

 SCARNA9L

small Cajal body-specific RNA 9-like

−63

0.028

 SNORD14E

small nucleolar RNA, C/D box 14E

−62

0.004

 SNORD59B

small nucleolar RNA, C/D box 59B

−61

0.032

 ZEB2

zinc finger E-box binding homeobox 2

−58

0.044

 LOC105370515

uncharacterized LOC105370515

−48

0.017

 H1F0

H1 histone family, member 0

−47

0.017

 USP12-AS1

USP12 antisense RNA 1

−47

0.023

 TRAJ56

T cell receptor alpha joining 56

−46

0.001

 CD1C

CD1c molecule

−42

0.001

 RNVU1–15

RNA, variant U1 small nuclear 15

−42

0.008

 LOC728093

putative POM121-like protein 1-like

−41

0.045

 LOC105374775

uncharacterized LOC105374775

−40

0.010

 LOC105375566

uncharacterized LOC105375566

−39

0.035

 LOC101927770

uncharacterized LOC101927770

−36

0.030

 FLT3

fms-related tyrosine kinase 3

−35

0.011

 OR2L1P

olfactory receptor, family 2, subfamily L, member 1 pseudogene

−34

0.030

 LOC100272216

uncharacterized LOC100272216

−34

0.028

 MERTK

MER proto-oncogene, tyrosine kinase

−34

0.023

 MIR486–2

microRNA 486–2

−33

0.029

 NFKBIZ

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta

−33

0.046

 LOC105378488

uncharacterized LOC105378488

−33

0.017

 MIR3160–1

microRNA 3160–1

−32

0.004

 YPEL5

yippee like 5

−32

0.002

 NLRP3

NLR family, pyrin domain containing 3

−31

0.035

 SNORA7B

small nucleolar RNA, H/ACA box 7B

−31

0.045

 HIST1H2BN

histone cluster 1, H2bn

−31

0.018

 LOC101929516

uncharacterized LOC101929516

−30

0.049

  1. Abbreviations: FC Fold change, GA Geographic atrophy, nAMD Neovascular age-related macular degeneration, PCV Polypoidal choroidal vasculopathy